Clinically, this might mean that levels of AKR1C3 in endometrioid endometrial cancer can be determined preoperatively on diagnostic tissue samples to allow prediction of the cancer behavior and stratification of the patients for more personalized treatments. The gene discussed is AKR1C3; the disease is cancer.